Calcium And Vitamin D Reduce The Risk Of Skin Tumors.
Certain women at danger for developing melanoma, the most inhuman form of skin cancer, may detached the likelihood in half by taking vitamin D with calcium supplements, a new study suggests bowtrolcoloncleanse. "It looks liking for there is some promising evidence for vitamin D and calcium for prevention of melanoma in a high-risk group," said show the way researcher Dr Jean Tang, an assistant professor of dermatology at Stanford University School of Medicine.
The women most at jeopardize of developing the life-threatening cancer are those who have had a above-named non-melanoma form of skin cancer, such as basal cell or squamous cell cancer, the researchers said. Vitamin D and calcium are prominent for their roles in bone growth, but they also affect other cells in the body effect. Some studies have shown that vitamin D and calcium are associated with discount risk of colon, breast, prostate and other cancers, the researchers said.
Tang speculated that cancer cells lurking in the coating of women who have had a former skin cancer may be waiting to develop into melanoma. "But if they take calcium and vitamin D that reduces the imperil of developing an actual tumor". As little as 400 ecumenic units (IU) of vitamin D daily may be protective.
The US Institute of Medicine now recommends 600 IU of vitamin D daily. Calcium has also been shown to bring down tumor increase in patients with colon cancer. "So maybe calcium has a role, too. I can't claim whether it was the calcium or the vitamin D that was important". But the combination seemed to convey a benefit.
Whether these results would be seen in men or babies women isn't known. But an earlier study led by Tang found a profit from vitamin D in reducing the risk of melanoma among older men. "More studies requisite to be done, because we want to make sure these results are true in other communities".
The set forth was published in the June 27 2011 online edition of the Journal of Clinical Oncology. For the study, Tang's side collected data on 36282 postmenopausal women, 50 to 79 years old, who took participation in the Women's Health Initiative study.
